首页> 外文OA文献 >Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer

【2h】

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer

机译：通过面板测序确定的肿瘤突变负担预测免疫治疗患者晚期胃癌患者后的存活

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jinchul Kim; Binnari Kim; So Young Kang; You Jeong Heo; Se Hoon Park; Seung Tae Kim; Won Ki Kang; Jeeyun Lee; Kyoung-Mee Kim;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer [J] . Jinchul Kim, Binnari Kim, So Young Kang, Frontiers in Oncology . 2020,第4期

机译：通过面板测序确定的肿瘤突变负担预测免疫治疗患者晚期胃癌患者后的存活
2. MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer [J] . Yue Yang, Jieyun Zhang, Yanxing Chen, Clinical and Translational Medicine . 2020,第4期

机译：<斜体> muc4 ，<斜视> muc16 ，<斜视> ttn 基因突变与预后相关，预测肿瘤突变负担和胃癌和泛癌的免疫疗法疗效
3. Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival [J] . Mary A. Wood, Benjamin R. Weeder, Julianne K. David, Genome Medicine . 2020,第1期

机译：肿瘤突变，颞抑制和其他变体的负担是癌症免疫疗法反应和整体生存的弱预测因子
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Computational assessment of somatic missense mutations detected in tumor sequencing studies with cancer-specific high-throughput annotation of somatic mutations (CHASM). [D] . Carter, Hannah. 2012

机译：具有肿瘤特异性高通量体细胞突变（CHASM）的肿瘤测序研究中检测到的体细胞错义突变的计算评估。
6. Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer [O] . Jinchul Kim, Binnari Kim, So Young Kang, 2020

机译：由面板测序确定的肿瘤突变负担预测晚期胃癌患者免疫治疗后的存活率
7. Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel [O] . Zhijie Wang, Jianchun Duan, Shangli Cai, 2019

机译：用下一代测序癌基因面板评估非小细胞肺癌患者免疫疗法的血肿突变负担的评估

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅